August 9, 2021 - In association with Heart Rhythm 2021, Biotronik today announced that the latest implantable cardiac ...
August 9, 2021 – Results from an international clinical trial show a significant reduction in risk of ventricular ...
August 9, 2021 — Adagio Medical Inc., a provider of catheter ablation technologies for atrial fibrillation (AF) and ...
August 5, 2021 — A prospective, non-randomized, multicenter, first-in-human clinical study found good diagnostic and ...
August 3, 2021 — A subgroup analysis of the EAST – AFNET 4 study population revealed early initiation of rhythm control ...
August 4, 2021 — Temporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial fibrillation ...
August 3, 2021 – Results from a new clinical trial show an increased risk of cardiac events, like sudden cardiac death ...
August 3, 2021 – A recent study unveiled a novel sinus node ablation technique that provides a safe and effective ...
August 3, 2021 – A new analysis of the Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA ...
August 3, 2021 — In association with Heart Rhythm 2021, Biotronik announced first enrollments in the landmark BIO ...
August 3, 2021 — Long-term follow-up data on hypertensive patients from the control group of the MODERATO II study who ...
Jass Brooks, vice president of global strategic marketing, Biosense Webster, explains four over-arching electrophysiolog ...
Samir Saba, M.D., co-director of the University of Pittsburgh Medical Center Heart and Vascular Institute, and chief ...
July 30, 2021 — A coalition of 10 U.S.-based cardiovascular societies have issued a statement today in support of all ...
July 30, 2021 – Innovative Health Inc. announced several new initiatives to increase savings from single-use device ...
August 09, 2021